
Floracene YC-Bewerbung
New York City
Floracene durchlief Y Combinator im Summer 2026-Batch als ein Healthcare-Unternehmen. Unten: Was das Unternehmen tut, wer es gegründet hat und seine Bewerbung bei YC, Frage für Frage im echten YC-Formular rekonstruiert.
- YC-Batch
- Summer 2026
- Branche
- Healthcare
- Standort
- New York City
- Teamgröße
- 2
- Status
- Active
- Gestartet
- 2026
Gründer
Asaph KupfermanFounder/CEO
Jonah KayeFounder/CTO
Was Floracene tut
Floracene lets any healthcare operator describe the internal tool they need and deploy it in one click - connected to production data, with read and write access scoped by the user. Think Lovable or Retool, except purpose-built for the needs of healthcare business that has no engineering team. The bottleneck in healthcare isn't building anymore. Anyone can vibecode an 80% solution in an afternoon, custom to their own workflow, with people already on staff. The tool then dies locally on the builder’s computer, because IT (correctly) won't let anyone deploy a tool touching PHI without first-class authentication and permissioning. Our first customer had multiple employees who had each built useful tools and dashboards locally, but couldn’t actually share these with coworkers or connect to their core practice data. Within weeks of implementing Floracene, they were able to consolidate their BI tooling into Floracene and shipped 4 net-new to production. A staggering ~$200B is spent on administrative software in healthcare every year in the US. Tens of thousands of those companies still run core operations on spreadsheets, and we're at the top of the first inning of AI adoption. Asaph and Jonah met on the hospitals team at Palantir two years ago, and have each spent the last four years in the plumbing of US healthcare: claims, eligibility, and payor contracting. Asaph was an early PM at Garner. Jonah was a founding engineer at Metriport (YC S22) after starting his own fax-automation startup for fertility clinics.
Floracenes YC-Bewerbung, rekonstruiert
Y Combinator Bewerbung
Floracene, Summer 2026 Batch. Die echten Fragen des Antrags, beantwortet aus öffentlichen Daten.
- Founders2
- Company7
- Progress7
- Idea4
- Equity3
- Curious2
- Batch Preference1
Company
Floracene
Vibecode & deploy HIPAA tools, no engineers needed
Floracene lets any healthcare operator describe and deploy the internal tool they need in one click, fully HIPAA-compliant. We connect those tools to production data, with read/write access scoped by user, so PHI is actually protected and shareable internally. It's like Lovable or Retool, but purpose-built for US healthcare teams that don't have engineers. Our users go from spreadsheet chaos and local scripts to actual production tools connected to their real data.
We live in New York City, NY, and will stay based here after YC.
NYC is where our healthcare customers and networks are. We're close to the market: most healthtech in the US happens here.
21 weitere Antworten in der vollständigen Bewerbung
Founders, Progress, Idea, Equity, Curious, Batch Preference sind in der Vollversion. Erstelle ein kostenloses Konto, um es in YC Insights neben jedem anderen YC-Batch zu öffnen.
Häufig gestellte Fragen
Ist das die echte YC-Bewerbung von Floracene?
Nein. Y Combinator hält eingereichte Bewerbungen privat. Dies ist eine Rekonstruktion: die echten Fragen des YC-Formulars, beantwortet aus den öffentlichen Daten von Floracene (Veröffentlichungsnotizen, Gründerhintergründe, Produktbeschreibung). Sie zeigt, wie sich ein Unternehmen wie Floracene bei YC präsentieren würde, nicht den Text, den sie eingereicht haben.
In welchem YC-Batch war Floracene?
Floracene war Teil des Y Combinator Summer 2026-Batches.
Wer hat Floracene gegründet?
Floracene wurde von Asaph Kupferman, Jonah Kaye gegründet.
Was macht Floracene?
Vibecode + deploy HIPAA-compliant internal tools, no eng team needed
Wie lese ich die vollständige, rekonstruierte Bewerbung?
Erstelle ein kostenloses Round Funded Konto. Die vollständige 26-Antwort-Version der Bewerbung von Floracene, und jede andere YC-Kohorte, findest du in YC Insights.